Principal Scientist as Clinical Imaging Lead

The Position

Are you an expert in Translational Medicine and Retinal Imaging?

Do you bring a strong interest in drug development as well as hands‑on experience with ophthalmic imaging technologies and image analysis? Join our newly established Global Experimental Medicine organization, where we apply innovative translational strategies—including biomarkers, clinical pharmacology, pharmacometrics and digital approaches—across the entire clinical development pipeline.
We drive projects rapidly and rigorously from first‑in‑human through proof of concept (PoC) to submission, leveraging state‑of‑the‑art technologies and advanced data analytics to generate integrated insights into dose‑exposure‑biomarker‑response relationships and enable Precision Medicine that delivers differentiated therapies.

Join us in shaping the future of medicine – apply now! 

This position can be filled in different countries. 

If you want to apply for the position in the USA, please use this link: coming soon

If you want to apply for the position in Ingelheim or Biberach click "Apply now".

This position has a hybrid setup with approximately 2-3 days per week on site.

This position is part time eligible with 80%.

Tasks & responsibilities

• In your new role, you will support drug development projects in the transition from research to clinical development and up to clinical phase III, including submission, by providing your expertise in clinical imaging biomarkers with strong focus on ophthalmic imaging technologies and image analysis. 
• Furthermore, you will successfully implement biomarker strategies in clinical trials and translational studies in close collaboration with Clinical Operations as well as with academic partners and CROs.
• Together with other early clinical development functions, you will ensure that the (imaging) biomarker data package supports a PoC in alignment with the Target Product Profile.
• You will be closely working with trial teams ensuring input for Clinical trial protocols and supporting the image transfer and imaging biomarker data transfer in clinical trials across all drug development phases.
• In addition, you will establish a network of leading academic partners to ensure a continuous exchange about ophthalmic imaging/image analysis methodologies and in vivo biomarkers across projects.
• You will design and lead experimental medicine studies to validate clinical imaging biomarkers in collaboration with internal and external partners.

Requirements

• PhD/OD or equivalent in Biomedical Engineering, Bio-/Medical Physics, Biology, Optometry or comparable with a strong track record of independent clinical/research activities in the field of clinical imaging
• Multiple years of postdoctoral experience or equivalent working experience; working experience in a pharmaceutical or diagnostic company is a plus
• Knowledge in implementing ophthalmic imaging, e.g., OCT, OCT-A, CFP, FAF, FA, and image analysis technologies
• Deep understanding of the acquisition and analysis of imaging data and linkage between imaging markers and clinical endpoints
• Good knowledge about relevant regulatory regulations applicable for clinical imaging and drug development, e.g., Good Clinical Practice (GCP) and FDA industry guidance
• Able to project opinions and knowledge with confidence, authority, respect, and diplomacy when interacting with all levels of Boehringer Ingelheim colleagues and external partners
• Collaborative, innovative, self-directed, with outstanding team-working and communication skills
• Excellent English - both spoken and written

Ready to contact us?

If you have any questions about the job posting or process - please contact our HR Direct Team, Tel: +49 (0) 6132 77-3330 or via mail: hr.de@boehringer-ingelheim.com

Recruitment process:
Step 1: Online application - The job posting is presumably online until March 20th, 2026. We reserve the right to take the posting offline beforehand. Applications up to March 4th, 2026 are guaranteed to be considered.
Step 2: Virtual meeting in the period from early till late March
Step 3: On-site interviews beginning in April

Please submit your application documents in English.